Anthem Biosciences Schedules Board Meeting to Approve Q2 and H1'27 Results
Anthem Biosciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Anthem Biosciences Schedules Board Meeting to Approve Q2 and H1'27 Results Anthem Biosciences Limited announced that its Board of Directors will meet on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in the company's equity shares remains closed from 1st Oct'26 until the close of trading hours on 5th Nov'26, which is 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Anthem Biosciences Ltd
- Transcript of Q2 & H1 FY27 Earnings Conference Call 路 06 Nov 2026
- Audio recording of Earnings Call for the quarter ended September 30, 2026. 路 05 Nov 2026
- Intimation of Schedule of Analyst Meet/Institutional Meet 路 05 Nov 2026
- Investors presentation for the financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Press release for the financial results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Submission of the outcome of the Board Meeting held on November 03, 2026, for approval of the Unaudited Financial results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Submission of outcome of the Board Meeting approving the Unaudited Financial results for the quarter and half year ended September 30, 2026, on November 03, 2026 路 03 Nov 2026
- Anthem Biosciences Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the period ended September 30, 2026. 路 03 Nov 2026
